GB2245830A - Medicament and cosmetics for treating skin and hair conditions - Google Patents

Medicament and cosmetics for treating skin and hair conditions Download PDF

Info

Publication number
GB2245830A
GB2245830A GB9112619A GB9112619A GB2245830A GB 2245830 A GB2245830 A GB 2245830A GB 9112619 A GB9112619 A GB 9112619A GB 9112619 A GB9112619 A GB 9112619A GB 2245830 A GB2245830 A GB 2245830A
Authority
GB
United Kingdom
Prior art keywords
cedrus
medicament
eczema
gum tragacanth
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9112619A
Other versions
GB2245830B (en
GB9112619D0 (en
Inventor
Ghomi Mina Safai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016141A external-priority patent/GB9016141D0/en
Priority claimed from GB909013133A external-priority patent/GB9013133D0/en
Application filed by Individual filed Critical Individual
Priority to GB9421341A priority Critical patent/GB2280112B/en
Publication of GB9112619D0 publication Critical patent/GB9112619D0/en
Publication of GB2245830A publication Critical patent/GB2245830A/en
Application granted granted Critical
Publication of GB2245830B publication Critical patent/GB2245830B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9767Pinaceae [Pine family], e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/06Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065Preparations for temporary colouring the hair, e.g. direct dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)

Abstract

Gum tragacanth is effective in reducing inflammation caused by psoriasis and eczema. Topical application of a gel containing 5% gum is effective. Decoctions of cedrus (dried Cedrus spp leaves) are also effective.

Description

MEDICAMENTS AND COSMETICS FOR TREATING SKIN AND HAIR CONDITIONS This invention relates to medicaments and cosmetics for treating skin conditions including but not exclusively dermatitis, psoriasis and eczema. The invention also has utility in cosmetic hair treatment by reversing greying.
Psoriasis and eczema cause much distress. Those afflicted suffer from discomfort and pain occasioned by the disease. The degree of discomfort is perhaps not full appreciated by those having the misfortune to suffer. Psoriasis is characterised by unsightly circumscribed red skin patches covered with white scale.
Eczema is characterised by, sometimes intense, itching, redness and oozing vesicular lesions. Those affected suffer not only from as it were the medical effects of the complaint but also the physical effects. Sufferers can be very upset by their physical appearance in that damage is done to the self-image and also the sufferer feels that he or she is being stared at by others.
Eczema while having an indeterminate number of causes is known in may cases to be aggravated by stress. It is possible that a vicious circle can ensue. A person may suffer from a small conspicuous patch of eczema. The stress occasioned by loss of self-image and real or imagined looked from by-passers leads to further spreading and so on.
Greying of hair so far as is known causes no damage to the body. The damage to the ego can be notoriously severe.
The invention seeks to alleviate the symptoms of these complaints in at least some cases. It must however be appreciated that neither psoriasis, dermatitis nor eczema may properly be considered to be single disease.
A more accurate analysis is that the complaints are constellations of similar symptoms invoked by a variety of causes. Accordingly alleviation can not be expected in all cases. Nevertheless the invention has more than a placebo effect.
According to the invention there is provided the use of gum tragacanth in the manufacture of a medicament for the treatment of psoriasis, dermatitis, eczema or dandruff.
According to the invention there is provided a method of improving the appearance of a mammal afflicted by psoriasis, eczema or dandruff by topical application of gum tragacanth.
According to the invention there is provided Cedrus spp leaves as a medicament.
According to the invention is provided the use of Cedrus spp leaves in the manufacture of a medicament for the treatment of psoriasis, eczema or dandruff.
According to the invention there is provided a method of improving the appearance of a mammal afflicted by psoriasis, eczema, dandruff or by topical application of Cedrus spp leaves.
Gum tragacanth is well known and is a glassy exudate from Astraalus spp especially Astraalus pummifer.
Typical uses are as an excipient as a thickening agent and as a suspending agent.
It has been unexpectedly found that topical application of Gum Tragcanth is in may cases efficacious in relieving the complaints hereinbefore described.
Typically application regimes include using a gel based on the gum as a shampoo which is used in the usual way. If desired detergent may be added. For the treatment of skin conditions the gel may be applied alone allowed to stand on the skin for a short time, 5 minutes to 1 hours preferably 10 minutes to 30 minutes and then washed off. Alternatively it may be applied together with some form of base material.
The following compositions are non-limiting examples GEL Ingredient Amount/g Gum tragacanth 4 (powdered) Deionized Water 200 The water is warmed to 450C. The gum is added with stirring and the mixture allowed to stand and cool. The gum dissolves to give an almost colourless solution which becomes more viscous on standing. After 8 hours a gel is applied to the afflicted area and washed off after some time. An immediate cooling sensation is noted and after daily or thrice weekly application considerable alleviation of symptoms is noted.
If it is desired to keep the gel for extended periods preservative such as alkyl especially methy hydroxybenzoate should be added.
The gum tragacanth can be incorporated in other composition such as for example a soap-based shampoo.
Soap-based Shampoo Ingredient Amount/g Potassium coconut oil soap 25 Potassium olive oil soap 5 95% Ethanol 12 Glycerol 1 Gum Tragacanth 4 Methyl hydroxybenzoate 0.2 Potassium citrate 1 Deionized Water 50 The gum tragacanth is dispersed in half the water which is warmed and contains the sodium citrate. The remaining ingredients are dissolved in the rest of the water. The two solutions are stirred together to give a viscous liquid shampoo suitable for hair and or body.
The citrate serves to reduce the viscosity of the gum.
The hydroxybenzoate is a preservative.
Colour and fragrance may be added if desired.
Preferably they are not used as they can irritate sensitive skin.
Soapless Shampoo Ingredient Amount/g Triethanolamine dodecyl 38 sulphate Laurylethanolamide 12 Sodium citrate 0.5 Methyl hydroxybenzoate 0.2 Propyl hydroxybenzoate 0.05 Gum Tragacanth 5 Water 45 The water is warmed and the ingredients dispersed into it with stirring.
GEL Amount /g Ingredient 95% Ethanol 10 Gum tragacanth 5 Glycerol 2 Water 9.5 The gum, ethanol and water (70g) are stirred vigorously. The glycerol is added with stirring. Water is added to make up to 100 ml. The composition forms a gel which can be applied to the skin. It dries to give a film and should be washed off after about 20 minutes.
Other active ingredients may be added if desired but this is not essential. There are no clearly defined limits to the amount of gum of use in the invention.
Compositions containing more than about 15wt% are generally too viscous whereas those containing less than about 0.5wt% contain too little active to be rapidly effective. Preferred ranges are of the order of 1 to 10 wt% more preferably 2 to 8 wt% especially 3 to 6 wt%.
Both gum tragacanth and cedrus compositions are also effective in reducing skin inflammation, non specific erythrema and itching. It may be desirable to apply them for example to sun-burn as cooling compositions. Both compositions are usuable as skin cleansers for sensitive skin and are effective as excortication agents.
Cedrus spp leaves have also been found to have utility in alleviating the aforementioned conditions.
Cedrus leaves are collected from a range of species especially Cedrus libani primarily from the Middle East including Iraq and Iran. The leaves are dried at low temperature and crushed to give a fine, pale green powder. Because Cedrus spp are not deciduous and leaves are always in a range of states of development the time of harvesting is not of crucial importance. A decoction of the powder prepared with hot water is pale coloured.
When applied o the skin it has been found to reduce inflammation especially when caused by psoriasis or eczema. Application may be required daily or thrice weekly for some time before a significant improvement is noted.
The following compositions are non-limiting examples Ingredient Amount/ml Powdered dried cedrus 5 Deionized Water 200 Warm water at 450C is poured over the powder and stirred. The liquor rapidly acquires some colour but is allowed to cool by standing. The liquor is decanted from the powder. Afflicted skin areas are bathed with the liquor. After allowing contact for about five minutes the skin is patted dry.
The cedrus may be incorporated into a conventional shampoo or cream base for application. Ethanolic or other organic extraction of the leaves results after removal of the solvent in an oil which is efficacious. The oil or powder or decoction may be incorporated in any base for topical treatment. Examples include the shampoo bases hereinbefore described with or without the gum, preservative and citrate. Application to the hair can reduce or reverse age-related greying of the hair.
Suitable strengths of decoction can be found by routine experiment. It is unlikely that any significant extra benefit can be obtained by using more than 20% cedrus (based on dry powder to final composition by volume). Similarly less than 0.58 is unlikely to have significantly greater than placebo effect. Preferred amounts are in the range of 1 to 15%, more preferably 2 to 10%, especially 3 to 6%.
The cedrus leaves may be presented in other forms.

Claims (11)

1. A cosmetic method of improving the appearance of a mammal afflicted with psoriasis, eczema, dandruff or age related grey hair by topical application of a composition comprising an extract of dried leaves of Cedrus spp.
2. A cosmetic method as claimed in claim 1 wherein the Cedrus spp is Cedrus libani
3. A cosmetic method of improving the appearance of a mammal by topical application of an extract of Cedrus spp leaves substantially as described herein.
4. The dried leaves of Cedrus spp especially as a Cedrus libani medicament.
5. The use of dried leaves of Cedrus spp especially Cedrus libani in the manufacture of a medicament for the treatment of psoriasis, eczema or dermatitis.
6. A cosmetic method of improving the appearance of a mammal afflicted with psoriasis, eczema or dandruff by topical application of a composition comprising gum tragacanth to afflicted areas.
7. A cosmetic method as claimed in claim 6 wherein the composition is an aqueous gel of gum tragacanth.
8. A cosmetic method as claimed in claim 7 wherein the composition further comprises detergent, preservative or viscosity reducing agent.
9. A cosmetic method of improving the appearance of a mammal by topical application of gum tragacanth substantially as described herein.
10 Gum tragacanth as a medicament.
11. The use of gum tragacanth in the manufacture of a medicament of the treatment of psoriasis and eczema.
GB9112619A 1990-06-12 1991-06-12 Medicaments for treating skin comprising gum tragacanth Expired - Fee Related GB2245830B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9421341A GB2280112B (en) 1990-06-12 1991-06-12 Medicaments and cosmetics comprising cedrus extracts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016141A GB9016141D0 (en) 1990-06-12 1990-06-12 Cedrus powder
GB909013133A GB9013133D0 (en) 1990-06-12 1990-06-12 Cedrus powder

Publications (3)

Publication Number Publication Date
GB9112619D0 GB9112619D0 (en) 1991-07-31
GB2245830A true GB2245830A (en) 1992-01-15
GB2245830B GB2245830B (en) 1995-02-08

Family

ID=26297198

Family Applications (2)

Application Number Title Priority Date Filing Date
GB9112619A Expired - Fee Related GB2245830B (en) 1990-06-12 1991-06-12 Medicaments for treating skin comprising gum tragacanth
GB919112590A Pending GB9112590D0 (en) 1990-06-12 1991-06-12 Medicaments and cosmetics for treating skin and hair conditions

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB919112590A Pending GB9112590D0 (en) 1990-06-12 1991-06-12 Medicaments and cosmetics for treating skin and hair conditions

Country Status (1)

Country Link
GB (2) GB2245830B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB450596A (en) * 1934-12-13 1936-07-13 Karl Jungmann Improvements in the manufacture of preparations for protecting and sealing wounds
GB771768A (en) * 1953-11-19 1957-04-03 Warner Lambert Pharmaceutical Improved dental therapeutic compositions
GB781150A (en) * 1955-12-22 1957-08-14 Kisaku Ibe Cosmetic and hair tonic preparations
GB793379A (en) * 1954-08-02 1958-04-16 Warner Lambert Pharmaceutical Improvements in or relating to hygenci compositions
GB829426A (en) * 1955-09-01 1960-03-02 Allied Lab Inc Corrective shampoos containing cadmium sulfide
JPS5883643A (en) * 1981-11-13 1983-05-19 Kuraray Co Ltd Polyprenyl composition or compound and their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163800A (en) * 1977-08-17 1979-08-07 The Procter & Gamble Company Topical composition and treatment of skin lesions therewith

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB450596A (en) * 1934-12-13 1936-07-13 Karl Jungmann Improvements in the manufacture of preparations for protecting and sealing wounds
GB771768A (en) * 1953-11-19 1957-04-03 Warner Lambert Pharmaceutical Improved dental therapeutic compositions
GB793379A (en) * 1954-08-02 1958-04-16 Warner Lambert Pharmaceutical Improvements in or relating to hygenci compositions
GB829426A (en) * 1955-09-01 1960-03-02 Allied Lab Inc Corrective shampoos containing cadmium sulfide
GB781150A (en) * 1955-12-22 1957-08-14 Kisaku Ibe Cosmetic and hair tonic preparations
JPS5883643A (en) * 1981-11-13 1983-05-19 Kuraray Co Ltd Polyprenyl composition or compound and their preparation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"The Extra Pharmacopeia" Martindale, (25th Edition) (1967)- pages 2-4 *
The Pharmaceutical Codex (11th Edition) (1982) - page 953 *
WPI abstract 83-62106 K/26 & JP 58083643 A *

Also Published As

Publication number Publication date
GB9112590D0 (en) 1991-07-31
GB2245830B (en) 1995-02-08
GB9112619D0 (en) 1991-07-31

Similar Documents

Publication Publication Date Title
JPH0215022A (en) Anti-imflammatory skin wetting composition and preparation thereof
AU639721B2 (en) Aloe water, preparation process and compositions containing it
Aglawe et al. Formulation and evaluation of herbal face pack
US9642887B1 (en) Anti-blepharitis compositions and their use
JPH0676311B2 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for the treatment of skin wrinkles and hyperpigmentation.
KR100879094B1 (en) Cosmetics formulation containing natural essential oils and its hydrosols
JP2006321758A (en) Cosmetic
Londhe et al. Formulation and Evaluation of Clay Face Pack.
WO2001085112A2 (en) Shaving cream formulations
US5849302A (en) Medicaments and cosmetics comprising Zizyphus spina-christi extracts
GB2245830A (en) Medicament and cosmetics for treating skin and hair conditions
CN113081933A (en) Acne-removing composition and preparation method and application thereof
KR102459024B1 (en) Cosmetic composition comprising mixed extract of verbena hybrida voss, cyclamen persicum mill. and saintpaulia ionantha h. wendl. for moisturizing the skin
US20030082130A1 (en) Hair and scalp treatment composition
KR102071600B1 (en) Cream composition manufacturing method for preventing of sensitive-skin and skin-trouble
JPH0256409A (en) Cosmetic containing bi-and trivalent iron salt blended therein
GB2280112A (en) Medicament and cosmetics for treating skin and hair conditions
KR102429344B1 (en) A cosmetic composition for anti-dandruff comprising extract of Polygala tenuifolia or Lycium chinense
KR20220001161A (en) Composition for skin protection, including extracts derived from natural products
Sharma et al. Formulation and evaluation of herbal cold cream
CN113768805A (en) Use of 4- (3-ethoxy-4-hydroxyphenyl) alkyl ketones as skin soothing agents
JPH1045559A (en) Cosmetic
KR100327674B1 (en) A cosmetic composition of lightening and removing effects in the melanin-like pigmentation
JPS62238207A (en) Cosmetic
JPH0517202B2 (en)

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20100612